S. 3754 · 115th Congress
CURE High Drug Prices Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
BlumenthalSponsor3 cosponsors · 3 D
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
What it does: CRS summary · Introduced in Senate · Dec 13, 2018
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
This bill prohibits price gouging by manufacturers of certain prescription drugs that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: CURE High Drug Prices Act
Also known as: Combatting Unreasonable Rises and Excessively High Drug Prices Act
Latest action (Dec 13, 2018): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Dec 13, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.